Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Noted, but the reason for the share price doubling in recent weeks is only 201. Nothing else has changed.
All assets are priced in based on the market’s expectation of whether/when they go ahead or not. Cash is king. We need this deal.
To be fair, Porky is right. If there’s no sign of 201 completing or cash flowing soon, the share price will sink. However, we have many indications that it’s all lining up to proceed. I’m kinda hoping EUDA just buys Valirx for £500m or so and then I can move on with my life.
It will be interesting to see how TRx shareholders are compensated for selling their shares to EUDA - I assume all or substantially all in the form of EUDA shares. If so, what % of the company they get will be interesting, given that indicates what TRx is bringing to the table (ie cash, pipeline etc) compared to EUDA’s existing market cap.
Assuming the EUDA board recommends the merger, I’m guessing this needs to be put to a shareholder vote. Wonder how quickly they could turn this.
Is there any news at EUDA? 20% up but I assume speculative?
Out of interest, how easy would it be to short a small AIM company with limited daily trading volume? Presumably if easy enough then it's not cheap?
I must admit I really don't understand what Porky is trying to achieve here. However, the frequency of his posts is very similar to those when he was ramping a couple of years back. Give it a couple more years and i'm sure he'll be back on side.
30 day exclusivity agreement between EUDA and TRx comes to an end early next month. Should get some news then anyway, not long now! Appreciate there’s plenty of downside risk here, Porky… but fingers crossed you’re wrong. Squeaky bum time!
To be clear though - we are only expecting to get a couple of million, right? (Unless the deal changes and TRx wants to buy 201 or our other IP outright)
If TRx can’t fund that in the near future it will be very disappointing!
Thanks Porky. I don’t think I can bring myself to commit any more funds given I’m down 2/3. That said, I do see the potential for significant upside here. I really don’t think £160k for a CEO’s salary is excessive. Progress is being made. Holding for the long term.
Thanks all, that’s really helpful. Seems like a question of when not if now. Fingers crossed for a big win this side of the new year!
Been a while since I posted on here, glad to see some positivity for once!
Looking at EUDA's financial statements, it does not have a huge amount of cash ($900k as of September 2022) and market cap only $44m. Assuming that EUDA will be funding the next phase of development (rather than TRx bringing its own cash to the table), I assume then that EUDA will either need to borrow or issue new shares to fund next stage of development etc. The former would be quick, the latter potentially a bit more time-consuming.
So... keen to understand this board's views on whether the above is a sensible assessment (in particular, whether we have cause to believe that TRx has independent funding); and if EUDA's cash levels could indicate we have a while to wait to get cash in the door?
Interested to see if this is actually any better than it was before for Valirx, there’s a lot of govt spin on the new SME R&D regime. Up to 31 March the benefit was actually worth 33.5% of qualifying spend, whereas now it’s only up to 27% (and only 18% for most SMEs). They have expanded what constitutes ‘qualifying’ but the rates have gone down and most businesses are worse off.
How exciting!
The company could well be in its death throes, although I certainly still have hope that my investment will prove fruitful! I wonder how consequential Wednesday’s meeting will be. Hopefully some positive news on underwriting the rights issue or, failing that, a positive proposal the broader existing investor base can get behind. Otherwise, down to zero we go…
Sorry, perhaps I’m blind… where is the reference to new docs being posted in the link? I can’t see anything since last February
This is all down to secret genius moves from the BOD. Go team
Appreciate the sentiment is overwhelmingly negative at the moment, I hope this can be reversed. I really do feel strongly that a change in the management team will be bad for the business. I definitely disagree with the negativity directed at Stella.
All we need is a few days of share price increases, with or without any news, and people will be talking about the BOD like they are geniuses.
Did I watch a different Q&A from everyone else? Just seen it.
I was impressed with Stella - she seems to be doing a great job of focussing the board on how they achieve their goals. She was able to clearly articulate how Val can move into a self-funding state and also grow the ultimate return to shareholders. With her guidance and oversight, I am in no doubt that Suzy will be able to deliver on what has been promised.
Looking forward to a self-funding business in the mid term.
On 201 - Stella didn’t seem overly keen and wanted to focus on lab etc. I think it’s right that we stop thinking so much about it. If it pans out then fine, but there’s many other opportunities for the business which have a greater chance of success, so it would be better for the management team to spend their time making the other opportunities work.
I am a sheep, what should I do.
Hi Adam. Can you please ask Stella what attracted her to the business, whether she has an idea of how long she will be on the board, and what her core goals are whilst she is there.
I'm sure covered on here before, if so sorry but I can't find it. My question: If/when Poly's board is satisfied that its financial position supports the payment of dividends, is there a mechanism for it to actually make such payments in GBP, in light of sanctions and the consequent restrictions on converting RUB to GBP? Or are we in a situation where there is no real ability to pay dividends until sanctions are removed?